| http://dbpedia.org/ontology/abstract
|
MOLMED is a biotechnology company founded … MOLMED is a biotechnology company founded in 1996 in Milan. It originally operated as contract manufacturing organization and other services for companies developing gene therapy and cell therapy products. In 2000 the company changed its business model and started to develop products of its own. In 2001 it signed an agreement with San Raffaele Hospital, that gave MolMed an option to license any gene therapy or cell therapy invention made at the hospital in the fields of cancer and HIV. The company was listed on the Milan Stock Exchange in 2008. In early 2015 MolMed partnered with GlaxoSmithKline related to GSK's acquisition of Strimvelis; MolMed had been involved in the early development of the product.d in the early development of the product.
, MolMed è una azienda italiana di biotecnol … MolMed è una azienda italiana di biotecnologie focalizzata su ricerca, sviluppo e validazione clinica di terapie innovative per la cura del cancro. La Società ha sede legale e operativa a Milano, all'interno del Parco scientifico biomedico San Raffaele (che include l'omonimo ospedale, l'istituto di ricerca ed un'università privata) e una sede operativa a Bresso presso OpenZone. La società è stata fondata da Claudio Bordignon nel 1996 come joint-venture tra Science Park Raf e Boehringer Mannheim, con l'obiettivo di creare una struttura specializzata nella manipolazione ex vivo di cellule umane per la fornitura di servizi di terapia genica per protocolli clinici sperimentali. Quotata alla Borsa italiana sul mercato MTA dal 2008.a Borsa italiana sul mercato MTA dal 2008.
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Molmed_Logo.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.molmed.com/financial-reports%3Flanguage=en +
|
| http://dbpedia.org/ontology/wikiPageID
|
42699281
|
| http://dbpedia.org/ontology/wikiPageLength
|
1790
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1011294233
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Cell_therapy +
, http://dbpedia.org/resource/File:Molmed_Logo.png +
, http://dbpedia.org/resource/San_Raffaele_Hospital +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Gene_therapy +
, http://dbpedia.org/resource/Contract_manufacturing_organization +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Category:Companies_established_in_1996 +
, http://dbpedia.org/resource/Strimvelis +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cn +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_established_in_1996 +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/MolMed?oldid=1011294233&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Molmed_Logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.molmed.com/financial-reports%3Flanguage=en +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/MolMed +
|
| owl:sameAs |
http://yago-knowledge.org/resource/MolMed +
, http://it.dbpedia.org/resource/MolMed +
, https://global.dbpedia.org/id/fain +
, http://rdf.freebase.com/ns/m.010hp2lk +
, http://dbpedia.org/resource/MolMed +
, http://www.wikidata.org/entity/Q17113918 +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1996 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
|
| rdfs:comment |
MOLMED is a biotechnology company founded … MOLMED is a biotechnology company founded in 1996 in Milan. It originally operated as contract manufacturing organization and other services for companies developing gene therapy and cell therapy products. In 2000 the company changed its business model and started to develop products of its own. In 2001 it signed an agreement with San Raffaele Hospital, that gave MolMed an option to license any gene therapy or cell therapy invention made at the hospital in the fields of cancer and HIV. The company was listed on the Milan Stock Exchange in 2008.isted on the Milan Stock Exchange in 2008.
, MolMed è una azienda italiana di biotecnol … MolMed è una azienda italiana di biotecnologie focalizzata su ricerca, sviluppo e validazione clinica di terapie innovative per la cura del cancro. La Società ha sede legale e operativa a Milano, all'interno del Parco scientifico biomedico San Raffaele (che include l'omonimo ospedale, l'istituto di ricerca ed un'università privata) e una sede operativa a Bresso presso OpenZone. La società è stata fondata da Claudio Bordignon nel 1996 come joint-venture tra Science Park Raf e Boehringer Mannheim, con l'obiettivo di creare una struttura specializzata nella manipolazione ex vivo di cellule umane per la fornitura di servizi di terapia genica per protocolli clinici sperimentali.enica per protocolli clinici sperimentali.
|
| rdfs:label |
MolMed
|
